4Toh CH,Giles AR.Waveform analysis of clotting test optical profiles in the diagnosis and management of disseminated intravascular coagulation(DIC).Clin Lab Haem,2002,24:321~ 327.
6Wang W,Boffa MB,Bjazar L,et al.A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor.J Biol Chem,1998,273 (42):27 176~27 181.
7Kurosawa S,Stearns-Kurosawa DJ,Carson CW,et al.Plasma levels of endothelial cell protein C receptor are elevated in patients with sepsis and systemic lupus erythematosus:lack of correlation with thrombomodulin suggests involvement of different pathological processes.Blood,1998,91(2):725~727.
9Vasse M,Guegan-Massardier E,Borg JY,et al.Frequency of protein Z deficiency in patients with ischaemic stroke.Lancet,2001,357(9 260):933~934.
10Gigarel N,Frydman N,Burlet P,et al.Single cell co-amplification of polymorphic markers for the indirect preimplantation genetic diagnosis of hemophilia A,X-linked adreno leukodystrophy,X-linked hydrocephalus and incontinentia pigmenti loci on Xq28.Hum Genet,2004,114(3):298~305.
二级参考文献13
1[1]Fukudome K, Esmon CT. Identification cloning and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol hem, 1994, 269: 26486-26491.
2[2]Stearns-Kurosawa DJ, Kurosawa S, Mollica JS, et al. The endothelial cell protein C receptor augments protein C activation by the thrombinthrombomodulin complex. Proc Natl Acad Sci USA, 1996, 93: 10212-10216.
3[3]Esmon CT, Xu J, Gu JM, et al. Endothelial protein C receptor.Thrombosis and Haemostasis, 1999, 82: 251-258.
4[4]Kurosawa S, Stearns-urosawa DJ, Hiadri N, et al. Identification of functional endothelial protein C receptor in human plasma. J Clin Invest, 1997, 100:411-418.
5[5]Fukudome K, Ye X, Tsuneyoshi N, et al. Activation mechanism of anticoagulant protein C in large blood vessels involving the endothelial cell protein C receptor. J Exp Med, 1998, 187:1029-1035.
6[6]Laszik Z, Mitro A, Taylor FB, et al. Human protein C receptor is pressent primarily on endothelium of large blood vessels: implications for the control of the protein C pathway. Circulation, 1997, 96: 3633-3640.
7[8]Kurosawa S, Stearns-Kurosawa DJ, Carson CW, et al. Plasma levels of endothelial cell protein C receptor are elevated in patients with sepis and systemic lupus erythematosus: lack of correlation with thrombomodulin suggests involvement of different pathological processes(letter). Blood,1998, 91:724-728.
8[9]Franchi FP, Faioni EM, Biguzzi E, et al. Expression of gene involved in hemostasis and cell adhesion in human coronary atherosclerotic plaques. Thromb and Haemost, 1999, (Suppl) :445.
10Abrams CS, Ellison N, Budzynski AZ, et al. Direct detection of activated platelets and platelet-derived microparticles in humans. Blood, 1990,75:128-138.
6Faioni EM, Ferrero S, Fontana G, et al. Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease [J]. Crit Care Med,2004, 32(5 Suppl): S266-S270.
7Lu XG, Tong JF, Zhang J, et al. Clinical study of plasma thrombomodulin detection [J]. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 2007, 15(1):112-116.
8Thorand B, Baumert J, Herder C, et al. Soluble thrombomodulin as a predictor of type 2 diabetes: results from the MONICA/ KORA Augsburg case-cohort study, 1984-1998 [J]. Diabetologia, 2007, 50(3): 545-548.
9Uszynski M, Zekanowska E, Kotzbach M, et al. Protein C, protein S, and thrombomodulin in amniotie fluid. A preliminary study[J]. J Perinat Med, 2006, 34(4): 289-292.
10Strandberg K, Svensson PJ, Ohlin AK. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity [J]. Thromb Res, 2007,121(2) : 145- 151.